Page last updated: 2024-08-23

paclitaxel and Coronary Disease

paclitaxel has been researched along with Coronary Disease in 178 studies

Research

Studies (178)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	141 (79.21)	29.6817
2010's	37 (20.79)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Codner, P; Gurm, HS; Motivala, A	1
Akasaka, T; Hirata, K; Imanishi, T; Ino, Y; Ishibashi, K; Kashiwagi, M; Kitabata, H; Komukai, K; Kubo, T; Mizukoshi, M; Takarada, S; Takemoto, K; Tanaka, A; Tanimoto, T	1
Whitlow, P	1
Amano, H; Eguchi, H; Fuku, Y; Goto, T; Habara, S; Hasegawa, D; Hayakawa, Y; Hosogi, S; Hyoudou, Y; Ichinohe, T; Izawa, Y; Kadota, K; Kato, H; Kubo, S; Mitsudo, K; Miyake, K; Nakamura, M; Otsuru, S; Shigemoto, Y; Tada, T; Tanaka, H	1
Bedogni, F; Berti, S; Biondi-Zoccai, G; Colombo, A; Cortese, B; Cremonesi, A; Limbruno, U; Sgueglia, GA	1
Alfonso, F	1
Byrne, RA; Cassese, S; Desch, S; Kastrati, A; King, L; Lauer, B; Pache, J; Schömig, A; Tada, T; Thiele, H	1
Allocco, DJ; Christen, T; Garratt, KN; Jenkins, RG; Kereiakes, DJ; Lee, DP; Mauri, L; Pow, TK; Weaver, WD; Winters, KJ	2
Collet, JP; Montalescot, G; Silvain, J	1
Allocco, DJ; Ball, M; Bertolet, B; Cannon, LA; Dauber, I; Dawkins, KD; Foster, M; Kereiakes, DJ; Nersesov, AY; Underwood, PL	1
Banning, AP; Colombo, A; Escaned, J; Feldman, T; Gunn, JP; Holmes, DR; Iqbal, J; Kappetein, AP; Mack, MJ; Mohr, FW; Morice, MC; Serruys, PW; Stahle, E; Steyerberg, EW; Zhang, YJ	1
Baliulis, G; Corbett, S; Curzen, N; Kaarne, M; Olsen, S; Rawlins, J; Roubelakis, A	1
Bagan, P; Couffinhal, JC; Dakhil, B; Gordienco, A; Hernigou, J; Longuet, P	1
Buch, AN; Shah, AH	1
Jeger, RV; Pfisterer, ME	1
Alfonso, F; Bethencourt, A; Cárdenas, A; Cuesta, J; Fernández, C; García Del Blanco, B; García-Touchard, A; Gonzalo, N; Jiménez-Quevedo, P; Lázaro-García, R; Masotti, M; Moreu, J; Otaegui, I; Pérez-Vizcayno, MJ; Rivero, F; Sanchís, J; Veláquez, M; Zueco, J	1
Alquier, L; Cohen, J; Maryanoff, CA; Reed, G; Vas, G	1
Bonello, L; de Labriolle, A; Kent, KM; Okabe, T; Pichard, AD; Pinto Slottow, TL; Roy, P; Satler, LF; Smith, K; Steinberg, DH; Suddath, WO; Torguson, R; Waksman, R; Xue, Z	1
Boland, P; Collins, M; Dangas, G; Fahy, M; Franklin-Bond, T; Gupta, A; Kim, YH; Kirtane, AJ; Kodali, S; Lansky, AJ; Leon, MB; Mehran, R; Mintz, G; Moses, JW; Solinas, E; Stone, GW; Syros, G	1
Airoldi, F; Antoniucci, D; Barbagallo, R; Cera, M; Chieffo, A; Colombo, A; Di Mario, C; Furuichi, S; Godino, C; Goktekin, O; Grube, E; Latib, A; Morici, N; Reimers, B; Romagnoli, E; Sangiorgi, GM; Tamburino, C	1
Aoki, J; Cambier, PA; Cannon, L; Dawkins, KD; Ellis, SG; Greenberg, J; Grube, E; Mandinov, L; Mann, JT; Mintz, GS; Stone, GW; Weissman, NJ; Yu, A	1
Airoldi, F; Carlino, M; Chieffo, A; Colombo, A; Corbett, SJ; Cosgrave, J; Cristell, N; Godino, C; Latib, A; Montorfano, M; Morici, N; Qasim, A; Tavano, D	1
Mahler, V; Pfoch, L; Sticherling, M	1
Chen, J; Chen, JL; Gao, RL; Gao, Z; Li, JJ; Liu, HB; Qiao, SB; Qin, XW; Wu, YJ; Xu, B; Yang, YJ; Yao, M; You, SJ; Yuan, JQ	1
Daemen, J; Kukreja, N; Serruys, PW; van Domburg, RT; van Twisk, PH	1
Chow, WH; Ho, HH; Jim, MH; Ko, RL; Lau, CP; Siu, CW; Yiu, KH	1
Bøttcher, M; Hansen, KN; Jensen, LO; Johnsen, SP; Kaltoft, A; Krusell, LR; Lassen, JF; Maeng, M; Pedersen, L; Rasmussen, K; Sørensen, HT; Thayssen, P; Thuesen, L; Tilsted, HH	1
Chronos, N; Conway, D; Jabara, R; Molema, W; Robinson, K	1
Alonso-Briales, JH; de Teresa-Galván, E; Domínguez-Franco, AJ; Hernández-García, JM; Jiménez-Navarro, MF; Leruite-Martín, I; Linde-Estrella, AL; Olalla-Mercadé, E; Pérez-González, O	1
Capodanno, D; Di Salvo, ME; Marzà, F; Ruggero Galassi, A; Tamburino, C; Tomasello, SD	1
Erl, A; Hoppmann, P; Kastrati, A; Koch, W; Mehilli, J; Schömig, A; Tiroch, K; Türk, S	1
García de Lara, J; Hurtado, JA; Lacunza, J; Pinar, E; Ramón Gimeno, J; Valdés Chávarri, M; Valdesuso, R	1
Bestehorn, HP; Buettner, HJ; Comberg, T; Ferenc, M; Gick, M; Kienzle, RP; Neumann, FJ; Werner, KD; Zhao, M	1
Brown, JR; DeVries, JT; Friedman, BJ; Hettleman, BD; Jayne, JE; Kaplan, AV; Malenka, DJ; Niles, NW; Robb, JF; Sidhu, MS; Thompson, CA; Yang, RC	1
Haase, J; Ruef, J; Schwarz, F; Störger, H	1
Arruda, JA; Barbosa, MR; Brito, FS; Caramori, PR; Lemos, PA; Lima, AA; Lima, VC; Martinez, EE; Medeiros, CR; Moulin, B; Oliveira, LA; Perin, MA; Ribeiro, EE	1
Shen, WF	1
Airaksinen, KE; Biancari, F; Billinger, M; Hess, O; Karjalainen, PP; Raeber, L; Ylitalo, A	1
Bezerra, HG; Costa, MA; Guagliumi, G; Kyono, H; Musumeci, G; Rosenthal, N; Sirbu, V; Tahara, S	1
Anthopoulos, PL; Antonelis, I; Gavaliatsis, I; Gavrielatos, G; Ifantis, G; Pappas, LK; Salachas, A	1
Akin, I; Bufe, A; Eckardt, L; Kuck, KH; Nienaber, CA; Reinecke, H; Richardt, G; Schneider, S; Senges, J	1
Iijima, R; Nakamura, M; Sugi, K; Yazaki, Y	1
Bongo, AS; Buffon, A; De Servi, S; Lazzero, M; Lupi, A; Navarese, EP; Sansa, M; Serra, A	1
Michishita, I	1
Applegate, RJ; Farhat, N; Hermiller, JB; Lansky, AJ; Ng, VG; Simonton, CA; Sood, P; Stone, GW; Su, X; Sudhir, K; Yaqub, M	1
Alswies, A; Carnero-Alcázar, M; Cobiella Carnicer, J; Fuentes Ferrer, ME; Maroto Castellanos, LC; Rodríguez Hernández, JE; Silva Guisasola, JA	1
Fearon, WF; Hunt, SA; Ikeno, F; Lee, DP; Ng, MK; Tremmel, JA; Yeung, AC	1
Makino, K; Nakamura, M	1
Amoroso, N; Bangalore, S; Byrne, RA; Cutlip, DE; Feit, F; Fusaro, M; Kirtane, AJ; Kumar, S; Slater, J; Williams, DO	1
Fuke, S; Ikeda, T; Kawai, H; Morimoto, Y; Ono, T; Saito, H; Sato, T	1
Mazurova, VV; Sukhorukov, OE; Zakharova, OV	1
Aude, YW; Garza, L; Saucedo, JF	1
Garces, K	1
Choi, D; Ho, DS; Hong, MK; Jang, Y; Lam, R; Lee, CW; Mintz, GS; Park, SJ; Park, SW; Raizner, AE; Shim, WH; Weissman, NJ	1
Amann, FW	1
Ishiwata, S; Kitai, T; Yamaguchi, T	1
Guagliumi, G; Musumeci, G; Tespili, M; Valsecchi, O; Vassileva, A	1
Carrieri, L; Catuzzo, B; Destefanis, P; Gagnor, A; Grosso Marra, W; Moretti, C; Oliaro, E; Omedè, PL; Sciuto, F; Sheiban, I; Trevi, GP; Truffa, A	1
Rothman, MT; Smith, EJ	1
Lee, TH	1
Hung, JS; Lau, KW; Mak, KH; Sigwart, U	1
Starcević, B; Vagić, JS	1
Raja, SG	1
Baluom, M; Benet, LZ; Ikeno, F; Kaneda, H; Lyons, J; Rezaee, M	1
Gross, TP; Muni, NI	1
Degertekin, M; Lemos, PA; Saia, F; Serruys, PW	1
Ansara, AJ; Dobesh, PP; Enders, JM; Stacy, ZA	1
King, SB	1
Betge, S; Figulla, HR; Krack, A; Prochnau, D; Schwarz, G; Werner, GS	1
Legrand, V; Scheen, AJ; Warzee, F	1
Moussa, I; Yang, YM	1
Airoldi, F; Bonizzoni, E; Carlino, M; Chieffo, A; Colombo, A; Iakovou, I; Michev, I; Montorfano, M; Sangiorgi, MG; Stankovic, G; Tsagalou, E; Vitrella, G	1
Ayello, EA; Oliver, B; Sharma, SK	1
Ioannidis, JP; Karvouni, E; Katritsis, DG	1
Ellis, SG; Kimmelstiel, C; Kosinski, E; Leon, MB; McGarry, TF; Mehran, R; Mishkel, GJ; Nikolsky, E; Russell, ME; Stone, GW	1
Gershlick, AH; Jilaihawi, H; Ng, E	1
Abbate, A; Agostoni, P; Biasucci, LM; Biondi-Zoccai, GG; Burzotta, F; Colombo, A; Crea, F; Lotrionte, M; Testa, L; Vetrovec, GW	1
Albin, G; Corey, W; Ellis, SG; Hirsch, C; Lasala, JM; Leon, MB; Mehran, R; Moses, JW; Nikolsky, E; Russell, ME; Stone, GW	1
Costa, RA; Ellis, SG; Lansky, AJ; Leon, MB; Lui, HK; Mehran, R; Midei, MG; Mooney, M; Russell, ME; Stone, GW; Strickland, W	1
Bergin, P; Caputo, R; Cox, DA; Ellis, SG; Greenberg, J; Hermiller, J; Koglin, JJ; Lasala, JM; Mann, JT; O'shaughnessy, C; Popma, JJ; Stone, GW; Turco, M	1
Kereiakes, DJ; Krucoff, MW; Kuntz, RE; Mauri, L	1
Bergin, P; Caputo, R; Cox, DA; Ellis, SG; Greenberg, J; Hermiller, J; Koglin, J; Kutcher, M; Mann, JT; Mooney, M; O'Shaughnessy, C; Russell, ME; Stone, GW; Strickland, W; Turco, M; Weissman, NJ; Wong, SC	1
Marzocchi, A; Saia, F; Serruys, PW	1
Aoki, J; de Feyter, P; Garcia-Garcia, HM; McFadden, E; Ong, AT; Rodriguez-Granillo, GA; Serruys, PW; Sianos, G; Tsuchida, K; Valgimigli, M; van der Giessen, WJ; van Domburg, R; van Mieghem, CA	1
Billinger, M; Corti, R; Eberli, FR; Egger, M; Hess, OM; Jüni, P; Lüscher, T; Maier, W; Meier, B; Räber, L; Remondino, A; Roffi, M; Seiler, C; Sütsch, G; Togni, M; Tüller, D; Wenaweser, P; Windecker, S	1
Dibra, A; Dirschinger, J; Kastrati, A; Mehilli, J; Pache, J; Schömig, A; Schühlen, H; Ulm, K; von Beckerath, N; Wessely, R	1
Moliterno, DJ	1
Alarcón, JA; Arribas, JM; Ruiz, V	1
Waksman, R; Wolfram, RM	1
Bonvini, RF; Verin, V	1
Czupryniak, L; Loba, J; Pawlowski, M	1
Jang, IK; Jneid, H; Palacios, I	1
Chen, J; Chen, JL; Dai, J; Gao, RL; Liu, HB; Ma, WH; Qiao, SB; Qin, XW; Wu, YJ; Xu, B; Yang, YJ; Yao, M; You, SJ; Yuan, JQ	2
Marso, SP; Safley, DM	1
Casey, CW; Ellis, SG; Gordon, P; Halkin, A; Leon, MB; Matthews, R; Mehran, R; Russell, ME; Stone, GW; Wilson, BH	1
Bass, TA	1
Betge, S; Figulla, HR; Fritzenwanger, M; Krack, A; Prochnau, D; Schwarz, G; Werner, GS	1
Klein, LW	1
Kaneda, H	1
Airoldi, F; Carlino, M; Chieffo, A; Colombo, A; Cosgrave, J; Ge, L; Iakovou, I; Melzi, G; Michev, I; Montorfano, M; Stancovic, G; Stankovic, G; Tsagalou, E	1
Kutryk, MJ; Ong, AT; Serruys, PW	1
Conti, G; De Luca, L; De Persio, G; Di Roma, A; Fedele, F; Paroli, M; Sardella, G	1
Corti, R; Eberli, FR; Luscher, TF; Maier, W; Neuenschwanden, C; Ramteke, GB; Roffi, M; Sutsch, G	1
Agostoni, P; Airoldi, F; Antoniucci, D; Biondi-Zoccai, GG; Chieffo, A; Colombo, A; Cosgrave, J; Di Mario, C; Goktekin, O; Grube, E; Iakovou, I; Michev, I; Reimers, B; Sangiorgi, GM; Tamburino, C; Tassanawiwat, W	1
Demirtaş, E; Ide, T; Işik, E; Iyisoy, A; Köz, C; Kurşaklioğlu, H; Töre, HF; Yildirim, V	1
Moussa, I	1
Han, YL; Jing, QM; Luan, B; Ma, YY; Wang, SL; Wang, XZ	1
De Feyter, P; de Jaegere, P; Garcia-Garcia, HM; Malagutti, P; Polad, J; Regar, E; Rodriguez-Granillo, GA; Serruys, PW; Tsuchida, K; Valgimigli, M; Van der Giessen, WJ	1
Nordmann, A	1
Chu, CS; Lai, WT; Lee, KT; Lee, ST; Lin, CT; Lin, TH; Sheu, SH; Voon, WC	1
Buellesfeld, L; Gerckens, U; Grube, E; Lim, V; Mueller, R; Schmidt, T	1
Han, KH; Hong, MK; Jang, JS; Kim, JJ; Kim, YH; Lee, BK; Lee, CW; Park, DW; Park, SJ; Park, SW	1
Anderson, HV; Hemstreet, P	1
Abrar, S; Dhakam, S; Hameed, A; Jafary, F; Kazmi, K; Nadeem, N; Rahman, N; Tai, J; Tipoo Sultan, FA	1
Chu, WW; Clavijo, L; Gevorkian, N; Kent, KM; Kuchulakanti, PK; Mishra, S; Pichard, AD; Satler, LF; Suddath, WO; Torguson, R; Waksman, R; Wolfram, R; Xue, Z	1
Dibra, A; Elezi, S; Folkerts, U; Heigl, S; Kastrati, A; Mehilli, J; Schömig, A	1
Bakhai, A; Berezin, RH; Clark, MA; Cohen, DJ; Cox, DA; Ellis, SG; Hermiller, JB; Lacey, MJ; Lahue, BJ; Lavelle, TA; Mahoney, E; Russell, ME; Shi, C; Stone, GW	1
Vaitkus, PT	1
Airoldi, F; Carlino, M; Chieffo, A; Colombo, A; Cosgrave, J; Finci, L; Iakovou, I; Michev, I; Montorfano, M; Sangiorgi, G; Stankovic, G	1
Ormerod, O; Schrale, R	1
Alfonso, F; Angiolillo, DJ; Bass, TA; Cervinka, P; Corros, C; Costa, MA; Futamatsu, H; Hernandez-Antolin, R; Jiang, J; Jimenez-Quevedo, P; Macaya, C; Morikawa-Futamatsu, K; Sabaté, M	1
Antoñanzas, F; Mainar, V; Russell, S	1
Abizaid, A; Chan, C; Gaxiola, E; Kaul, U; Lim, YT; Lopez-Cuellar, J; Patel, T; Ramesh, S; Rodriguez, A; Russell, ME; Sinha, N; Tan, HC	1
Abbott, JD; Kip, KE; Williams, DO	1
Behl, A; Malhotra, S; Pandhi, P; Shafiq, N; Sharma, YP	1
Chu, WW; Clavijo, LC; Kent, KM; Kuchulakanti, PK; Pichard, AD; Satler, LF; Suddath, WO; Torguson, R; Waksman, R; Wang, B	1
Bavry, AA; Bhatt, DL; Borek, PP; Helton, TJ; Kumbhani, DJ; Mood, GR	1
Delgado, A; Esteban, F; Hernandez, E; Herrador, J; Mazuelos, F; Medina, A; Melian, F; Ojeda, S; Pan, M; Pavlovic, D; Romero, M; Segura, J; Suárez de Lezo, J	1
Couppié, P; De Poli, F; Dickelé, MC; Fellinger, F; Hanssen, M; Thalouarn, C	1
Applegate, RJ; Baki, TT; Gandhi, SK; Kutcher, MA; Little, WC; Sacrinty, MT; Santos, RM	1
Altamura, L; Biondi-Zoccai, G; Brancati, M; Burzotta, F; Crea, F; Leone, AM; Mazzari, MA; Mongiardo, R; Niccoli, G; Rebuzzi, AG; Romagnoli, E; Schiavoni, G; Siviglia, M; Trani, C	1
Chang, G; Czer, L; DeRobertis, M; Forrester, J; Jamal, F; Kapoor, N; Kedia, G; Lee, MS; Makkar, RR; Trento, A; Zimmer, R	1
De Felice, F; Fiorilli, R; Violini, R	1
Cutlip, DE; D'Agostino, R; Ho, KK; Hsieh, WH; Massaro, JM; Mauri, L	1
James, SK; Lagerqvist, B; Lindbäck, J; Nilsson, T; Stenestrand, U; Wallentin, L	1
Colombo, A; Cutlip, DE; Dawkins, KD; Ellis, SG; Fahy, M; Grube, E; Kirtane, AJ; Leon, MB; Mehran, R; Morice, MC; Moses, JW; Pocock, SJ; Schampaert, E; Schofer, J; Stone, GW	1
Maisel, WH	1
Hong, MK; Kim, JJ; Kim, YH; Lee, CW; Park, DW; Park, SJ; Park, SW; Yun, SC	1
Buch, AN; Javaid, A; Kent, KM; Mishra, S; Okabe, T; Pichard, AD; Roy, P; Satler, LF; Slottow, TL; Smith, KA; Steinberg, DH; Suddath, WO; Torguson, R; Waksman, R; Xue, Z	1
Banning, AP; Bruining, N; Colombo, A; Drzewiecki, J; Dudek, D; Koglin, J; Rademaker, TA; Russell, ME; Schiele, F; Serruys, PW; Tsuchida, K; van Es, GA; Zhou, Z; Zmudka, K	1
De Benedetti, E; Urban, P	1
Chen, JL; Gao, RL; Hou, Q; Qiao, SB; Xu, B; Yang, YJ	1
Daemen, J; de Jaegere, PT; Denollet, J; Erdman, RA; Pedersen, SS; Serruys, PW; van de Sande, M; van Domburg, RT	1
Gao, RL	1
Agostoni, P; Airoldi, F; Chieffo, A; Colombo, A; Corvaja, N; Cosgrave, J; Ge, JB; Ge, L; Iakovou, I; Michev, I; Qian, JY; Sangiorgi, GM	1
Chen, J; Chen, JL; Dai, J; Gao, RL; Li, JJ; Liu, HB; Ma, WH; Qiao, SB; Qin, XW; Wu, YJ; Xia, R; Xu, B; Yang, YJ; Yao, M; You, SJ; Yuan, JQ	1
Ballert, NM; Baum, VC; de Souza, DG	1
Alfonso, F; Angiolillo, DJ; Bass, TA; Corros, C; Costa, MA; Futamatsu, H; Hernandez-Antolin, R; Jimenez-Quevedo, P; Kawaguchi, R; Macaya, C; Sabate, M; Suzuki, N	1
Agostoni, P; Airoldi, F; Babic, R; Biondi-Zoccai, GG; Carlino, M; Chieffo, A; Colombo, A; Corbett, S; Cosgrave, J; Melzi, G; Michev, I; Montorfano, M; Sangiorgi, GM	1
Burzotta, F; Choi, JH; Colombo, A; Gwon, HC; Hahn, JY; Romagnoli, E; Trani, C	1
Yamamoto, H	1
Allemann, S; Cervinka, P; de Lezo, JS; Diem, P; Dirksen, MT; Goy, JJ; Jüni, P; Kastrati, A; Kelbaek, H; Leon, MB; Meier, B; Menichelli, M; Morice, MC; Nordmann, AJ; Park, SJ; Petronio, AS; Pfisterer, ME; Reichenbach, S; Sabaté, M; Schömig, A; Spaulding, C; Stettler, C; Stone, GW; Suttorp, MJ; Trelle, S; Vermeersch, P; Wandel, S; Windecker, S; Zwahlen, M	1
Chieffo, A; Colombo, A	1
Banerjee, S; Berger, PB; Brilakis, ES	1
Bruskina, O; Ibrahim, M; Iijima, R; Kastrati, A; Markwardt, C; Mehilli, J; Ndrepepa, G; Pache, J; Schömig, A	1
De Luca, L; Favero, L; Ferrero, V; Galassi, AR; Gaspardone, A; Ghini, AS; Gioffrè, G; Prati, F; Reimers, B; Ribichini, F; Tamburino, C; Tomai, F	1
Singh, B	1
Bernheim, A; Brunner-La Rocca, HP; Buser, PT; Jeger, R; Kaiser, C; Osswald, S; Pfisterer, M; Zellweger, MJ	1
Aliot, E; Angiol, M; Chodek-Hingray, A; Ethevenot, G; Lemoine, J; Moulin, F; Popovic, B	1
Böhm, M; Boxberger, M; Cremers, B; Kühler, M; Mahnkopf, D; Scheller, B	1
Buszman, P; Gil, R; Jaklik, A; Janczak, J; Kałuza, GL; Kiesz, S; Kinasz, L; Kondys, M; Kośmider, M; Król, M; Milewski, K; Przewłocki, T; Rzeszutko, Ł; Rzeźniczak, J; Trznadel, S; Wójcik, J; Zurakowski, A	1
Barbagallo, R; Capranzano, P; Ciriminna, S; Fiscella, A; Galassi, AR; Grassi, R; Nicosia, A; Patti, A; Saccone, G; Stabile, A; Tagliareni, F; Tamburino, C; Tolaro, S; Ussia, G	1
Colombo, A; Dawkins, KD; Ellis, SG; Fahy, M; Grube, E; Kirtane, AJ; Leon, MB; Mehran, R; Moses, JW; Popma, JJ; Stone, GW	1
Chen, J; Chen, JL; Gao, RL; Li, JJ; Liu, HB; Qiao, SB; Qin, XW; Wu, YJ; Xu, B; Yang, YJ; Yao, M; Yuan, JQ	1
Alfonso, F; Botas, J; de la Torre-Hernández, JM; Diarte, JA; Elizaga, J; Gomez-Jaume, A; Hernández, F; Hernández, JM; Larman, M; Lopez-Minguez, JR; Lozano, I; Mauri, J; Nodar, JM; Perez de Prado, A; Pinar, E; Rodríguez-Collado, J; Rumoroso, JR; Sanchis, J; Sanmartin, M; Vazquez, JM	1
Bavry, AA; Bhatt, DL; Helton, TJ; Kamdar, AR; Kumbhani, DJ	1
Abugattás-de Torres, JP; Aldama-López, G; Calviño-Santos, R; Castro-Beiras, A; Flores-Ríos, X; Marzoa-Rivas, R; Piñón-Esteban, P; Salgado-Fernández, J; Vázquez-González, N; Vázquez-Rodríguez, JM	1
Ramondo, A; Razzolini, R; Tarantini, G	1
Buch, AN; Javaid, A; Kent, KM; Pichard, AD; Pinto Slottow, TL; Roy, P; Satler, LF; Smith, K; Steinberg, DH; Suddath, WO; Waksman, R; Xue, Z	1
Baim, D; Cannon, LA; Dawkins, KD; Ellis, SG; Grube, E; Kimura, M; Mandinov, L; Masud, Z; Mintz, GS; Stone, GW; Weissman, NJ	1
Bornstein, DA; Drachman, DE; Edelman, ER; Groothuis, AR; Kamath, KR; Nott, SH; Palasis, M; Rogers, C; Seifert, P; Yang, D	1
Kipshidze, N; Leon, MB; Moses, JW	1
Colombo, A; Liistro, F	1
Donahue, M; Kandzari, DE; Kay, J; Liao, L; O'Shea, JC; Rao, SV; Trichon, BH	1
Caixeta, A; Généreux, P; Kirtane, AJ; Madhavan, MV; Palmerini, T; Sanidas, E; Stone, GW; Yadav, M	1

Reviews

37 review(s) available for paclitaxel and Coronary Disease

Article	Year
Coronary Stents in Diabetic Patients: State of the Knowledge. Current cardiology reports, 2017, Volume: 19, Issue:4 Topics: Coronary Disease; Diabetic Angiopathies; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Treatment Outcome	2017
Pooled analysis of trials comparing titanium-nitride-oxide-coated stents with paclitaxel-eluting stents in patients undergoing coronary stenting. The Journal of invasive cardiology, 2010, Volume: 22, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Nitric Oxide; Paclitaxel; Risk Factors; Titanium; Treatment Outcome	2010
Drug-eluting stents vs. bare metal stents in saphenous vein graft disease. Insights from a meta-analysis of 7,090 patients. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:2 Topics: Aged; Aged, 80 and over; Angioplasty; Bias; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Coronary Restenosis; Diabetic Angiopathies; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Paclitaxel; Postoperative Complications; Randomized Controlled Trials as Topic; Regression Analysis; Saphenous Vein; Sirolimus; Stents; Treatment Outcome	2011
[Paclitaxel-eluting stent]. Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69 Suppl 7 Topics: Coronary Disease; Drug-Eluting Stents; Evidence-Based Medicine; Humans; Paclitaxel	2011
Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ (Clinical research ed.), 2012, Aug-10, Volume: 345 Topics: Angioplasty, Balloon, Coronary; Bayes Theorem; Coronary Disease; Diabetes Complications; Drug-Eluting Stents; Follow-Up Studies; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Treatment Outcome	2012
Can we prevent in-stent restenosis? Current opinion in cardiology, 2002, Volume: 17, Issue:5 Topics: Angioplasty, Balloon, Coronary; Animals; Brachytherapy; Cell Cycle; Coated Materials, Biocompatible; Coronary Disease; Coronary Restenosis; Drug Delivery Systems; Gene Transfer Techniques; Humans; Paclitaxel; Sirolimus; Stents	2002
[Prevention of postangioplasty restenosis]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 4 Topics: Angioplasty, Balloon, Coronary; Atherectomy, Coronary; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Disease; Coronary Restenosis; Humans; ortho-Aminobenzoates; Paclitaxel; Probucol; Radiotherapy; Sirolimus; Stents; Trapidil	2003
Through the drug-eluting stent labyrinth. Italian heart journal : official journal of the Italian Federation of Cardiology, 2003, Volume: 4, Issue:4 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Disease; Coronary Restenosis; Costs and Cost Analysis; Humans; Immunosuppressive Agents; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents	2003
Antiproliferative coatings for the treatment of coronary heart disease:. what are the targets and which are the tools? Journal of interventional cardiology, 2003, Volume: 16, Issue:6 Topics: Antibiotics, Antineoplastic; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Disease; Coronary Restenosis; Forecasting; Humans; Immunosuppressive Agents; Paclitaxel; Risk Factors; Sirolimus; Stents	2003
Clinical impact of stent construction and design in percutaneous coronary intervention. American heart journal, 2004, Volume: 147, Issue:5 Topics: Biocompatible Materials; Coronary Disease; Coronary Restenosis; Drug Delivery Systems; Humans; Paclitaxel; Prosthesis Design; Sirolimus; Stents	2004
Drug-eluting stents: is it the beginning of the end for coronary artery bypass surgery? Chinese medical journal, 2004, Volume: 117, Issue:9 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Disease; Drug Delivery Systems; Estradiol; Everolimus; Humans; Paclitaxel; Sirolimus; Stents; Tacrolimus	2004
Drug-eluting stents: from randomized trials to the real world. Minerva cardioangiologica, 2004, Volume: 52, Issue:5 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Disease; Coronary Restenosis; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Paclitaxel; Polymers; Randomized Controlled Trials as Topic; Sirolimus; Stents	2004
Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease. Pharmacotherapy, 2004, Volume: 24, Issue:11 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents; Brachytherapy; Clinical Trials as Topic; Coronary Disease; Coronary Restenosis; Female; Humans; Male; Paclitaxel; Sirolimus; Stents	2004
From balloon angioplasty to drug-eluting stents: revolution or evolution? The American heart hospital journal, 2004,Spring, Volume: 2, Issue:2 Topics: Angioplasty, Balloon, Coronary; Anti-Infective Agents; Brachytherapy; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug Delivery Systems; Follow-Up Studies; Humans; Immunosuppressive Agents; Meta-Analysis as Topic; Multicenter Studies as Topic; Paclitaxel; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Time Factors	2004
[Percutaneous coronary angioplasty in diabetic patients: new prospects with drug-eluting stents]. Revue medicale de Liege, 2004, Volume: 59, Issue:12 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Diabetes Complications; Drug Delivery Systems; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents	2004
How drug-eluting stents keep coronary blood flowing. Nursing, 2005, Volume: 35, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Coronary Disease; Coronary Restenosis; Drug Delivery Systems; Equipment Design; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents	2005
Meta-analysis comparing drug-eluting stents with bare metal stents. The American journal of cardiology, 2005, Mar-01, Volume: 95, Issue:5 Topics: Chi-Square Distribution; Coated Materials, Biocompatible; Coronary Disease; Drug Implants; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents	2005
Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials. International journal of cardiology, 2005, Apr-08, Volume: 100, Issue:1 Topics: Coronary Disease; Everolimus; Humans; Immunosuppressive Agents; Odds Ratio; Paclitaxel; Prosthesis Design; Randomized Controlled Trials as Topic; Sirolimus; Stents	2005
Drug-eluting stents. The third revolution in percutaneous coronary intervention. Italian heart journal : official journal of the Italian Federation of Cardiology, 2005, Volume: 6, Issue:4 Topics: Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Disease; Coronary Restenosis; Drug Delivery Systems; Female; Humans; Male; Paclitaxel; Prognosis; Radiography; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Sirolimus; Stents; Treatment Outcome	2005
Diabetes and percutaneous coronary intervention in the setting of an acute coronary syndrome. Diabetes & vascular disease research, 2005, Volume: 2, Issue:3 Topics: Acute Disease; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Disease; Coronary Restenosis; Diabetes Complications; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Sirolimus; Stents; Syndrome	2005
Coronary-artery stents. The New England journal of medicine, 2006, Feb-02, Volume: 354, Issue:5 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Drug Administration Routes; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents	2006
[Drug-eluting stents: do they keep their promises?]. Praxis, 2006, Apr-12, Volume: 95, Issue:15 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Cost-Benefit Analysis; Drug Delivery Systems; Follow-Up Studies; Humans; Immunosuppressive Agents; Meta-Analysis as Topic; Mortality; Myocardial Infarction; Odds Ratio; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Time Factors	2006
Cypher versus Taxus: the stent war. Expert opinion on investigational drugs, 2006, Volume: 15, Issue:12 Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Combined Modality Therapy; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Diabetes Complications; Drug Implants; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents; Treatment Outcome	2006
Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. The American journal of medicine, 2006, Volume: 119, Issue:12 Topics: Coronary Disease; Drug Delivery Systems; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Risk Factors; Sirolimus; Stents; Thrombosis; Time Factors	2006
[Drug eluting stents in 2005: have the initial expectations been met?]. Annales de cardiologie et d'angeiologie, 2005, Volume: 54, Issue:6 Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Disease; Coronary Restenosis; Drug Delivery Systems; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents; Tubulin Modulators	2005
[Chronic total coronary occlusions: an overview]. Giornale italiano di cardiologia (2006), 2006, Volume: 7, Issue:12 Topics: Angioplasty, Balloon, Coronary; Angioplasty, Laser; Chronic Disease; Coronary Disease; Coronary Restenosis; Humans; Myocardial Revascularization; Paclitaxel; Stents; Treatment Outcome; Tubulin Modulators	2006
Stent thrombosis in randomized clinical trials of drug-eluting stents. The New England journal of medicine, 2007, Mar-08, Volume: 356, Issue:10 Topics: Angioplasty, Balloon, Coronary; Brachytherapy; Combined Modality Therapy; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Prosthesis Design; Prosthesis Failure; Randomized Controlled Trials as Topic; Sirolimus; Stents	2007
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. The New England journal of medicine, 2007, Mar-08, Volume: 356, Issue:10 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prosthesis Design; Prosthesis Failure; Randomized Controlled Trials as Topic; Sirolimus; Stents	2007
[Present circumstance around percutaneous coronary intervention (PCI): before and after drug eluting stent (DES) introduction]. Nihon Hoshasen Gijutsu Gakkai zasshi, 2007, Jun-20, Volume: 63, Issue:6 Topics: Angioplasty, Balloon, Coronary; Atherectomy; Coronary Disease; Female; Humans; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Sirolimus; Stents; Thrombosis	2007
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet (London, England), 2007, Sep-15, Volume: 370, Issue:9591 Topics: Anti-Bacterial Agents; Coronary Disease; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents	2007
Drug-eluting stent update 2007: part III: Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease). Circulation, 2007, Sep-18, Volume: 116, Issue:12 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Bypass; Coronary Disease; Coronary Restenosis; Drug Implants; Humans; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Saphenous Vein; Sirolimus; Stents; Treatment Outcome	2007
The risk of drug-eluting stent thrombosis with noncardiac surgery. Current cardiology reports, 2007, Volume: 9, Issue:5 Topics: Algorithms; Angioplasty, Balloon, Coronary; Anticoagulants; Coated Materials, Biocompatible; Coronary Disease; Endothelium, Vascular; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Postoperative Complications; Practice Guidelines as Topic; Prosthesis Design; Risk Assessment; Risk Factors; Stents; Surgical Procedures, Operative; Time Factors	2007
Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials. Journal of the American College of Cardiology, 2008, Feb-19, Volume: 51, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Retreatment; Risk Factors; Stents; Survival Analysis; Treatment Outcome	2008
The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials. American heart journal, 2008, Volume: 155, Issue:4 Topics: Aged; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents	2008
Towards defining the role of drug eluting stents. Minerva cardioangiologica, 2008, Volume: 56, Issue:1 Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coronary Disease; Coronary Restenosis; Drug Therapy, Combination; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Treatment Outcome	2008
Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus. The American journal of cardiology, 2008, May-01, Volume: 101, Issue:9 Topics: Chi-Square Distribution; Coronary Angiography; Coronary Disease; Coronary Vessels; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Randomized Controlled Trials as Topic; Statistics, Nonparametric; Stents; Tunica Intima; Ultrasonography, Interventional	2008
Prediction of coronary risk by SYNTAX and derived scores: synergy between percutaneous coronary intervention with taxus and cardiac surgery. Journal of the American College of Cardiology, 2013, Oct-01, Volume: 62, Issue:14 Topics: Cardiac Surgical Procedures; Coronary Disease; Drug-Eluting Stents; Humans; Percutaneous Coronary Intervention; Plant Extracts; Severity of Illness Index; Taxus	2013

Trials

31 trial(s) available for paclitaxel and Coronary Disease

Article	Year
Polymer-free sirolimus-eluting versus polymer-based paclitaxel-eluting stents: an individual patient data analysis of randomized trials. Revista espanola de cardiologia (English ed.), 2013, Volume: 66, Issue:6 Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Disease; Drug-Eluting Stents; Endpoint Determination; Female; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Treatment Outcome	2013
Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement. Circulation, 2015, Jan-06, Volume: 131, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aspirin; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Incidence; Internationality; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Pyridines; Thiophenes; Time Factors; Treatment Outcome	2015
Long-term follow-up of the platinum chromium TAXUS Element (ION) stent: The PERSEUS Workhorse and Small Vessel trial five-year results. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2015, Nov-15, Volume: 86, Issue:6 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Bayes Theorem; Chromium; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Patient Selection; Platinum; Prospective Studies; Prosthesis Design; Prosthesis Failure; Risk Assessment; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Survival Rate; Taxus; Time Factors; Treatment Outcome; United States	2015
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Car Circulation, 2015, Apr-07, Volume: 131, Issue:14 Topics: Aged; Biomarkers; Cardiovascular Agents; Combined Modality Therapy; Comorbidity; Coronary Artery Bypass; Coronary Disease; Drug Utilization; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Netherlands; Paclitaxel; Percutaneous Coronary Intervention; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Stroke; Treatment Outcome	2015
Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial. JACC. Cardiovascular interventions, 2016, 06-27, Volume: 9, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Catheters; Cardiovascular Agents; Coated Materials, Biocompatible; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Metals; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Risk Factors; Spain; Stents; Surveys and Questionnaires; Time Factors; Treatment Outcome	2016
Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials). The American journal of cardiology, 2008, Oct-15, Volume: 102, Issue:8 Topics: Aged; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Circulation; Coronary Disease; Creatinine; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Paclitaxel; Prospective Studies; Renal Insufficiency; Severity of Illness Index; Stents; Time Factors; Treatment Outcome; Tubulin Modulators; Ultrasonography, Interventional; Vascular Resistance	2008
Rationale and design for the PAINT randomized trial. Arquivos brasileiros de cardiologia, 2009, Volume: 93, Issue:6 Topics: Absorbable Implants; Adolescent; Angioplasty, Balloon, Coronary; Brazil; Cardiovascular Agents; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Epidemiologic Methods; Humans; Paclitaxel; Polymers; Prosthesis Design; Sirolimus; Treatment Outcome; Young Adult	2009
Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial. Heart (British Cardiac Society), 2010, Volume: 96, Issue:19 Topics: Aged; Coronary Disease; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Radiography; Sirolimus; Stents; Tomography, Optical Coherence; Treatment Outcome; Tubulin Modulators; Ultrasonography, Interventional	2010
Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial). The American journal of cardiology, 2011, Mar-15, Volume: 107, Issue:6 Topics: Coronary Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prospective Studies; Sex Factors; Single-Blind Method; Sirolimus; Treatment Outcome; Tubulin Modulators; Women	2011
A paclitaxel-eluting stent for the prevention of coronary restenosis. The New England journal of medicine, 2003, Apr-17, Volume: 348, Issue:16 Topics: Angiogenesis Inhibitors; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Restenosis; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperplasia; Male; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Tunica Intima; Ultrasonography, Interventional	2003
Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. Journal of the American College of Cardiology, 2004, Dec-21, Volume: 44, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Chronic Disease; Cohort Studies; Coronary Angiography; Coronary Disease; Coronary Restenosis; Diabetic Angiopathies; Female; Humans; Incidence; Male; Middle Aged; Paclitaxel; Secondary Prevention; Stents; Survival Analysis; Treatment Outcome	2004
Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial). The American journal of cardiology, 2005, Mar-15, Volume: 95, Issue:6 Topics: Aged; Angina Pectoris; Angina, Unstable; Angioplasty, Balloon, Coronary; Body Mass Index; Coronary Angiography; Coronary Disease; Coronary Restenosis; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Myocardial Ischemia; Obesity; Paclitaxel; Polymers; Proportional Hazards Models; Risk Factors; Stents	2005
Outcomes with the paclitaxel-eluting stent in patients with acute coronary syndromes: analysis from the TAXUS-IV trial. Journal of the American College of Cardiology, 2005, Apr-19, Volume: 45, Issue:8 Topics: Antineoplastic Agents; Coronary Disease; Coronary Restenosis; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Microvascular Angina; Middle Aged; Myocardial Revascularization; Paclitaxel; Prospective Studies; Stents	2005
Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. Journal of the American College of Cardiology, 2005, Apr-19, Volume: 45, Issue:8 Topics: Age Factors; Aged; Antineoplastic Agents; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Male; Myocardial Revascularization; Paclitaxel; Polymers; Sex Factors; Stents; Treatment Outcome	2005
Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. Journal of the American College of Cardiology, 2005, Apr-19, Volume: 45, Issue:8 Topics: Angina Pectoris; Antineoplastic Agents; Area Under Curve; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Recurrence; Stents; Treatment Outcome	2005
Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. Journal of the American College of Cardiology, 2005, Apr-19, Volume: 45, Issue:8 Topics: Antineoplastic Agents; Coronary Disease; Coronary Vessels; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Polymers; Stents; Tunica Intima; Ultrasonography, Interventional	2005
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. The New England journal of medicine, 2005, Aug-18, Volume: 353, Issue:7 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Single-Blind Method; Sirolimus; Stents; Survival Analysis	2005
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. The New England journal of medicine, 2005, Aug-18, Volume: 353, Issue:7 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Diabetes Complications; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Regression Analysis; Sirolimus; Stents; Survival Analysis	2005
Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial. American heart journal, 2005, Volume: 150, Issue:6 Topics: Aged; Coronary Disease; Coronary Restenosis; Creatinine; Delayed-Action Preparations; Female; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Paclitaxel; Risk Factors; Stents	2005
Comparison between sirolimus- and paclitaxel-eluting stent in T-cell subsets redistribution. The American journal of cardiology, 2006, Feb-15, Volume: 97, Issue:4 Topics: Aged; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Coronary Disease; Female; Flow Cytometry; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Stents; T-Lymphocyte Subsets	2006
Are drug-eluting stents cost-effective when compared with bare-metal stents in a real-world setting? Nature clinical practice. Cardiovascular medicine, 2006, Volume: 3, Issue:4 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Cost-Benefit Analysis; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Paclitaxel; Probability; Prosthesis Design; Risk Assessment; Sensitivity and Specificity; Sirolimus; Stents; Survival Rate; Treatment Outcome	2006
[Comparison of Rapamycin and Paclitaxel eluting stent in patients with multi-vessel coronary disease]. Zhonghua xin xue guan bing za zhi, 2006, Volume: 34, Issue:2 Topics: Angioplasty, Balloon, Coronary; Constriction, Pathologic; Coronary Disease; Drug-Eluting Stents; Follow-Up Studies; Humans; Paclitaxel; Sirolimus; Treatment Outcome	2006
Evaluation of a new polymer-coated paclitaxel-eluting stent for treatment of de novo lesions: six-month clinical and angiographic follow-up results of the APPLAUSE trial. The Journal of invasive cardiology, 2006, Volume: 18, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Coated Materials, Biocompatible; Coronary Angiography; Coronary Disease; Coronary Restenosis; Equipment Design; Follow-Up Studies; Humans; Metals; Middle Aged; Paclitaxel; Pilot Projects; Polymers; Stents; Treatment Outcome	2006
Drug-eluting stents for the treatment of bifurcation lesions: a randomized comparison between paclitaxel and sirolimus stents. American heart journal, 2007, Volume: 153, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Creatine Kinase; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Stents; Troponin I; Ultrasonography, Interventional	2007
Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trial. The American journal of cardiology, 2007, Mar-01, Volume: 99, Issue:5 Topics: Coronary Angiography; Coronary Disease; Equipment Design; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Paclitaxel; Stents; Time Factors; Treatment Outcome; Tubulin Modulators; Tunica Intima; Ultrasonography, Interventional	2007
[The clinical efficacy of sirolimus-eluting stents versus paclitaxel-eluting stents in complex and diffuse coronary lesions]. Zhonghua nei ke za zhi, 2006, Volume: 45, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Sirolimus; Stents; Treatment Outcome	2006
Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus. The international journal of cardiovascular imaging, 2008, Volume: 24, Issue:2 Topics: Analysis of Variance; Coronary Angiography; Coronary Disease; Diabetes Complications; Drug-Eluting Stents; Female; Humans; Hyperplasia; Imaging, Three-Dimensional; Male; Paclitaxel; Prospective Studies; Sirolimus; Stents; Tacrolimus; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional	2008
Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: the T-stenting and small protrusion technique (TAP-stenting). Report of bench testing and Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2007, Jul-01, Volume: 70, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Female; Humans; Italy; Korea; Male; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Radiography, Interventional; Severity of Illness Index; Sirolimus; Stents; Treatment Outcome; Ultrasonography, Interventional; Vascular Patency	2007
Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study. Diabetes care, 2008, Volume: 31, Issue:1 Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Coronary Angiography; Coronary Disease; Coronary Restenosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus	2008
Paclitaxel-eluting stent Taxcor: first application in man. Minerva cardioangiologica, 2007, Volume: 55, Issue:5 Topics: Aged; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Retrospective Studies; Treatment Outcome	2007
Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis. Lancet (London, England), 2007, Nov-03, Volume: 370, Issue:9598 Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Coronary Disease; Cost-Benefit Analysis; Female; Humans; Male; Middle Aged; Paclitaxel; Quality-Adjusted Life Years; Risk Factors; Sirolimus; Stents	2007

Other Studies

110 other study(ies) available for paclitaxel and Coronary Disease

Article	Year
Clinical significance of low signal intensity area surrounding stent struts identified by optical coherence tomography. International heart journal, 2013, Volume: 54, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Hyperplasia; Immunosuppressive Agents; Japan; Male; Middle Aged; Neointima; Outcome Assessment, Health Care; Paclitaxel; Postoperative Complications; Prospective Studies; Sirolimus; Stents; Tomography, Optical Coherence; Tubulin Modulators	2013
Drug-eluting stents. The Journal of invasive cardiology, 2004, Volume: 16, Issue:7 Suppl Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coronary Disease; Coronary Restenosis; Diabetic Angiopathies; Drug-Eluting Stents; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus	2004
Association between tissue characteristics evaluated with optical coherence tomography and mid-term results after paclitaxel-coated balloon dilatation for in-stent restenosis lesions: a comparison with plain old balloon angioplasty. European heart journal. Cardiovascular Imaging, 2014, Volume: 15, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Observer Variation; Paclitaxel; Reproducibility of Results; Retrospective Studies; Severity of Illness Index; Time Factors; Tomography, Optical Coherence; Treatment Outcome	2014
[SICI-GISE position paper on drug-coated balloon use in the coronary district]. Giornale italiano di cardiologia (2006), 2013, Volume: 14, Issue:10 Topics: Angioplasty, Balloon, Coronary; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Coronary Restenosis; Cost-Benefit Analysis; Drug-Eluting Stents; Equipment Design; Evidence-Based Medicine; Humans; Multicenter Studies as Topic; Myocardial Infarction; Neointima; Paclitaxel; Platelet Aggregation Inhibitors; Registries	2013
New drug-eluting stents: polymer-free, biodegradable polymers or bioabsorbable scaffolds? Revista espanola de cardiologia (English ed.), 2013, Volume: 66, Issue:6 Topics: Antineoplastic Agents, Phytogenic; Coronary Disease; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Paclitaxel; Sirolimus	2013
Long-term secondary prevention after high-risk stenting: a good drug for a bad stent. Circulation, 2015, Jan-06, Volume: 131, Issue:1 Topics: Aspirin; Coronary Disease; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Piperazines; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes	2015
Coronary artery rupture caused by stent infection: a rare complication. Circulation, 2015, Apr-07, Volume: 131, Issue:14 Topics: Angina, Unstable; Anti-Bacterial Agents; Chest Pain; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Drug-Eluting Stents; Emergencies; Floxacillin; Fusidic Acid; Humans; Internal Mammary-Coronary Artery Anastomosis; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prosthesis-Related Infections; Rupture, Spontaneous; Staphylococcal Infections; Ultrasonography; Ventricular Dysfunction, Left	2015
[Propionibacterium granulosum bare-metal stent infection after drug-eluting balloon]. Journal des maladies vasculaires, 2015, Volume: 40, Issue:4 Topics: Aged, 80 and over; Alloys; Amoxicillin; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Arteriosclerosis Obliterans; Bacteremia; Coronary Disease; Coronary Restenosis; Device Removal; Equipment Contamination; Female; Femoral Artery; Gentamicins; Gram-Positive Bacterial Infections; Humans; Immunosuppressive Agents; Paclitaxel; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Popliteal Artery; Propionibacterium; Prosthesis-Related Infections; Stents; Tomography, Emission-Computed, Single-Photon	2015
Letter by Shah and Buch regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement". Circulation, 2015, Sep-29, Volume: 132, Issue:13 Topics: Aspirin; Coronary Disease; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Piperazines; Purinergic P2Y Receptor Antagonists; Thiophenes	2015
Letter by Jeger and Pfisterer regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement". Circulation, 2015, Sep-29, Volume: 132, Issue:13 Topics: Aspirin; Coronary Disease; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Piperazines; Purinergic P2Y Receptor Antagonists; Thiophenes	2015
Response to letters regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement". Circulation, 2015, Sep-29, Volume: 132, Issue:13 Topics: Aspirin; Coronary Disease; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Piperazines; Purinergic P2Y Receptor Antagonists; Thiophenes	2015
Investigation of mass-balance issue in e-beam sterilized paclitaxel eluting coronary stents by SPME/GC-MS. Journal of pharmaceutical and biomedical analysis, 2008, Nov-04, Volume: 48, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Coronary Disease; Drug-Eluting Stents; Electrons; Gas Chromatography-Mass Spectrometry; Molecular Structure; Molecular Weight; Paclitaxel; Solid Phase Microextraction; Sterilization; Volatilization	2008
Two-year outcome of patients treated with sirolimus- versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry). The American journal of cardiology, 2008, Aug-01, Volume: 102, Issue:3 Topics: Aged; Coronary Disease; Coronary Thrombosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Paclitaxel; Sirolimus; Treatment Outcome	2008
Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. The American journal of cardiology, 2008, Aug-01, Volume: 102, Issue:3 Topics: Age Factors; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Sirolimus	2008
Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry). The American journal of cardiology, 2008, Oct-15, Volume: 102, Issue:8 Topics: Aged; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Disease; Coronary Vessels; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Paclitaxel; Prospective Studies; Registries; Severity of Illness Index; Time Factors; Treatment Outcome; Tubulin Modulators	2008
Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcations. American heart journal, 2008, Volume: 156, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Treatment Outcome	2008
Drug-eluting coronary stents: hypersensitivity reactions to paclitaxel. A case report. Dermatology (Basel, Switzerland), 2009, Volume: 218, Issue:1 Topics: Aged; Anaphylaxis; Anti-Allergic Agents; Cardiovascular Agents; Coronary Disease; Coronary Restenosis; Drug Hypersensitivity; Drug-Eluting Stents; Histamine H1 Antagonists; Humans; Male; Paclitaxel; Treatment Outcome	2009
[Effects of sirolimus-eluting stent and the paclitaxel-eluting stent: a three-year follow-up study]. Zhonghua yi xue za zhi, 2008, Jul-08, Volume: 88, Issue:26 Topics: Aged; Coronary Angiography; Coronary Disease; Drug-Eluting Stents; Follow-Up Studies; Humans; Immunosuppressive Agents; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Time Factors; Tubulin Modulators	2008
Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2008, Volume: 4, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coronary Disease; Coronary Restenosis; Disease-Free Survival; Drug-Eluting Stents; Female; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Metals; Middle Aged; Paclitaxel; Saphenous Vein; Sirolimus; Treatment Outcome	2008
Paclitaxel-eluting stent long-term outcomes in percutaneous saphenous vein graft interventions (PELOPS) study. The American journal of cardiology, 2009, Jan-15, Volume: 103, Issue:2 Topics: Aged; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Drug-Eluting Stents; Female; Humans; Logistic Models; Male; Paclitaxel; Proportional Hazards Models; Prospective Studies; Saphenous Vein; Treatment Outcome; Tubulin Modulators	2009
2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry). Journal of the American College of Cardiology, 2009, Feb-24, Volume: 53, Issue:8 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Sirolimus; Stents; Thrombosis	2009
Evaluation of a novel slow-release paclitaxel-eluting stent with a bioabsorbable polymeric surface coating. JACC. Cardiovascular interventions, 2008, Volume: 1, Issue:1 Topics: Animals; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Disease; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug-Eluting Stents; Lactic Acid; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prosthesis Design; Swine	2008
Comparison of medium-term outcomes obtained with drug-eluting stents and coronary artery bypass grafts in an unselected population of diabetic patients with multivessel coronary disease. Propensity score analysis. Revista espanola de cardiologia, 2009, Volume: 62, Issue:5 Topics: Aged; Antineoplastic Agents, Phytogenic; Cohort Studies; Coronary Artery Bypass; Coronary Disease; Diabetic Angiopathies; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Logistic Models; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Retrospective Studies; Sirolimus; Treatment Outcome	2009
Long-term follow-up after drug eluting stent implantation in left main trifurcations. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009, Volume: 5, Issue:4 Topics: Aged; Angioplasty; Coronary Angiography; Coronary Disease; Coronary Vessels; Drug-Eluting Stents; Equipment Design; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Tubulin Modulators	2009
No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents. JACC. Cardiovascular interventions, 2009, Volume: 2, Issue:11 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Chromosomes, Human, Pair 9; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Phenotype; Polymorphism, Single Nucleotide; Proportional Hazards Models; Risk Assessment; Risk Factors; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2009
Percutaneous coronary intervention in heavily calcified lesions using rotational atherectomy and paclitaxel-eluting stents: outcomes at one year. Revista espanola de cardiologia, 2010, Volume: 63, Issue:1 Topics: Aged; Atherectomy, Coronary; Calcinosis; Coronary Artery Disease; Coronary Disease; Drug-Eluting Stents; Female; Humans; Male; Paclitaxel; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome	2010
Long-term outcome of percutaneous catheter intervention for de novo coronary bifurcation lesions with drug-eluting stents or bare-metal stents. American heart journal, 2010, Volume: 159, Issue:3 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Disease; Drug-Eluting Stents; Female; Humans; Male; Metals; Middle Aged; Mortality; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Risk Factors; Sirolimus; Stents; Time Factors; Treatment Outcome	2010
Real world, long-term outcomes comparison between paclitaxel-eluting and sirolimus-eluting stent platforms. Journal of interventional cardiology, 2010, Volume: 23, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Angiography; Coronary Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Inpatients; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Prospective Studies; Registries; Sirolimus; Treatment Outcome	2010
Increased restenosis rates 12 months after coronary implantation of the sirolimus-eluting YUKON-choice stent compared to the paclitaxel-eluting TAXUS Stent. Clinical cardiology, 2010, Volume: 33, Issue:4 Topics: Aged; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Graft Occlusion, Vascular; Humans; Immunosuppressive Agents; Male; Paclitaxel; Prosthesis Design; Retrospective Studies; Sirolimus; Treatment Outcome; Tubulin Modulators	2010
Late and very late stent thrombosis after polymer-based sirolimus- or paclitaxel-eluting stent implantation in real-world clinical practice. Chinese medical journal, 2010, Apr-05, Volume: 123, Issue:7 Topics: Aspirin; Clopidogrel; Coronary Disease; Coronary Thrombosis; Drug-Eluting Stents; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Polymers; Sirolimus; Ticlopidine	2010
Clinical outcome and angiographic results with novel polysulfone polymer coating paclitaxel eluting stent in real-world clinical practice: a clinical centre registry. Medical science monitor : international medical journal of experimental and clinical research, 2010, Volume: 16, Issue:10 Topics: Aged; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Drug-Eluting Stents; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Polymers; Registries; Sulfones; Time Factors; Treatment Outcome	2010
Comparison of outcomes in patients with insulin-dependent versus non-insulin dependent diabetes mellitus receiving drug-eluting stents (from the first phase of the prospective multicenter German DES.DE registry). The American journal of cardiology, 2010, Nov-01, Volume: 106, Issue:9 Topics: Aged; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug-Eluting Stents; Female; Germany; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Logistic Models; Male; Paclitaxel; Prospective Studies; Registries; Sirolimus; Survival Rate; Treatment Outcome; Tubulin Modulators	2010
Relationship between renal function stage and clinical outcomes after paclitaxel-eluting stent implantation. Journal of cardiology, 2011, Volume: 57, Issue:1 Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Paclitaxel; Treatment Outcome	2011
The final answer? For the treatment of saphenous vein graft disease, drug-eluting stents vs. bare-metal stents. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:2 Topics: Angioplasty; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Meta-Analysis as Topic; Paclitaxel; Postoperative Complications; Randomized Controlled Trials as Topic; Saphenous Vein; Sirolimus; Stents; Treatment Outcome	2011
SYNTAX Score is associated with worse outcomes after off-pump coronary artery bypass grafting surgery for three-vessel or left main complex coronary disease. The Journal of thoracic and cardiovascular surgery, 2011, Volume: 142, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Artery Bypass, Off-Pump; Coronary Disease; Drug-Eluting Stents; Female; Health Status Indicators; Humans; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors	2011
Comparison of drug-eluting versus bare metal stents in cardiac allograft vasculopathy. The American journal of cardiology, 2011, Sep-01, Volume: 108, Issue:5 Topics: Aspirin; Chi-Square Distribution; Clopidogrel; Coronary Angiography; Coronary Disease; Drug-Eluting Stents; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Metals; Middle Aged; Paclitaxel; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Sirolimus; Stents; Ticlopidine; Transplantation, Homologous; Treatment Outcome; Tubulin Modulators	2011
Differences in clinical and angiographic outcomes with different drug-eluting stents in Japanese patients with and without diabetes mellitus. Journal of cardiology, 2012, Volume: 60, Issue:5 Topics: Aged; Aged, 80 and over; Asian People; Coronary Angiography; Coronary Disease; Coronary Restenosis; Diabetes Complications; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Percutaneous Coronary Intervention; Prognosis; Retrospective Studies; Sirolimus; Treatment Outcome	2012
[Comparing moderately late results of the application of stents coated with a medicinal antiproliferative agent for the treatment of patients with various forms of coronary heart disease: their efficacy and safety]. Klinicheskaia meditsina, 2012, Volume: 90, Issue:6 Topics: Adult; Cell Proliferation; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug-Eluting Stents; Endovascular Procedures; Follow-Up Studies; Humans; Paclitaxel; Sirolimus; Thrombosis; Time Factors; Treatment Outcome	2012
Dual antiplatelet therapy after stenting. More than 12 months of treatment might not be necessary. Harvard heart letter : from Harvard Medical School, 2012, Volume: 22, Issue:12 Topics: Aspirin; Coronary Disease; Coronary Restenosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Paclitaxel; Patient Education as Topic; Time Factors; United States	2012
Drug eluting stents: managing coronary artery stenosis following PTCA. Issues in emerging health technologies, 2002, Issue:40 Topics: Angioplasty, Balloon, Coronary; Canada; Clinical Trials as Topic; Constriction, Pathologic; Coronary Disease; Coronary Vessels; Cost-Benefit Analysis; Drug Approval; Drug Delivery Systems; Europe; European Union; Humans; Paclitaxel; Sirolimus; Stents; Treatment Outcome	2002
[Coronary stents]. Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:4 Topics: Angiogenesis Inhibitors; Angioplasty, Balloon, Coronary; Controlled Clinical Trials as Topic; Coronary Disease; Coronary Restenosis; Double-Blind Method; Follow-Up Studies; Humans; Paclitaxel; Prosthesis Design; Reoperation; Risk Factors; Sirolimus; Stents; Time Factors	2003
Evolving standard in the treatment of coronary artery disease. Drug-eluting stents. Minerva cardioangiologica, 2003, Volume: 51, Issue:5 Topics: Adult; Aged; Clinical Trials as Topic; Coronary Disease; Drug Delivery Systems; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Stents	2003
"Me-too" products--friend or foe? The New England journal of medicine, 2004, Jan-15, Volume: 350, Issue:3 Topics: Coronary Disease; Cost Savings; Cost-Benefit Analysis; Drug Costs; Economic Competition; Health Care Costs; Humans; Paclitaxel; Sirolimus; Stents; United States	2004
[Stents without restenosis--true or a myth?]. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2004, Volume: 58, Issue:2 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Humans; Paclitaxel; Sirolimus; Stents	2004
Novel percutaneous adventitial drug delivery system for regional vascular treatment. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2004, Volume: 63, Issue:2 Topics: Animals; Catheterization; Connective Tissue; Coronary Angiography; Coronary Disease; Drug Delivery Systems; Equipment Design; Equipment Safety; Feasibility Studies; Paclitaxel; Staining and Labeling; Swine; Tacrolimus	2004
Problems with drug-eluting coronary stents--the FDA perspective. The New England journal of medicine, 2004, Oct-14, Volume: 351, Issue:16 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Device Approval; Drug Delivery Systems; Equipment Failure; Humans; Paclitaxel; Prosthesis Design; Sirolimus; Stents; Thrombosis; United States; United States Food and Drug Administration	2004
Percutaneous coronary intervention and drug-eluting stents. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2005, Feb-01, Volume: 172, Issue:3 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Coronary Vessels; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents	2005
Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation, 2005, Feb-15, Volume: 111, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Restenosis; Coronary Vessels; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Risk Factors; Sirolimus; Stents; Treatment Outcome	2005
Symptomatic myocardial bridging--a niche indication for drug-eluting stents? International journal of cardiology, 2005, Mar-30, Volume: 99, Issue:3 Topics: Angioplasty, Balloon, Coronary; Chest Pain; Coated Materials, Biocompatible; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Paclitaxel; Stents	2005
Surrogates, substudies, and real clinical end points in trials of drug-eluting stents. Journal of the American College of Cardiology, 2005, Apr-19, Volume: 45, Issue:8 Topics: Antineoplastic Agents; Clinical Trials, Phase IV as Topic; Coronary Disease; Coronary Restenosis; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Research Design; Stents	2005
One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries. The Journal of invasive cardiology, 2005, Volume: 17, Issue:8 Topics: Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prospective Studies; Randomized Controlled Trials as Topic; Registries; Sirolimus; Stents; Time Factors; Treatment Outcome	2005
Healing Achilles--sirolimus versus paclitaxel. The New England journal of medicine, 2005, Aug-18, Volume: 353, Issue:7 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Humans; Paclitaxel; Sirolimus; Stents	2005
Drug-eluting coronary stents. The New England journal of medicine, 2005, Dec-01, Volume: 353, Issue:22 Topics: Coronary Disease; Coronary Restenosis; Data Interpretation, Statistical; Diabetes Complications; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents	2005
Drug-eluting coronary stents. The New England journal of medicine, 2005, Dec-01, Volume: 353, Issue:22 Topics: Coronary Disease; Coronary Restenosis; Diabetes Complications; Humans; Immunosuppressive Agents; Paclitaxel; Research Design; Sirolimus; Stents	2005
Drug-eluting coronary stents. The New England journal of medicine, 2005, Dec-01, Volume: 353, Issue:22 Topics: Coronary Angiography; Coronary Disease; Coronary Restenosis; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents	2005
Drug-eluting coronary stents. The New England journal of medicine, 2005, Dec-01, Volume: 353, Issue:22 Topics: Angiotensin II Type 2 Receptor Blockers; Blood Glucose; Confounding Factors, Epidemiologic; Coronary Disease; Coronary Restenosis; Diabetes Complications; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents	2005
Drug-eluting coronary stents. The New England journal of medicine, 2005, Dec-01, Volume: 353, Issue:22 Topics: Coronary Disease; Coronary Restenosis; Diabetes Complications; Humans; Immunosuppressive Agents; Paclitaxel; Sirolimus; Stents	2005
[Short and long-term therapeutic effects of rapamycin-eluting stent and paclitaxel-eluting stent in treatment of coronary disease with complicated lesions]. Zhonghua yi xue za zhi, 2005, Aug-17, Volume: 85, Issue:31 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Sirolimus; Stents; Treatment Outcome	2005
DES: technique still matters. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2006, Volume: 67, Issue:1 Topics: Antineoplastic Agents, Phytogenic; Coronary Disease; Graft Occlusion, Vascular; Humans; Logistic Models; Paclitaxel; Stents	2006
Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions: a strategy of extensive lesion coverage with drug-eluting stents. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2006, Volume: 67, Issue:1 Topics: Aged; Antineoplastic Agents, Phytogenic; Chronic Disease; Constriction, Pathologic; Coronary Angiography; Coronary Disease; Coronary Vessels; Female; Graft Occlusion, Vascular; Humans; Male; Middle Aged; Paclitaxel; Prosthesis Design; Retrospective Studies; Stents	2006
Are drug-eluting stents the preferred treatment for multivessel coronary artery disease? Journal of the American College of Cardiology, 2006, Jan-03, Volume: 47, Issue:1 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Disease; Coronary Restenosis; Humans; Paclitaxel; Sirolimus; Stents	2006
Intravascular ultrasound analysis of polymer-based paclitaxel-eluting stents. Journal of the American College of Cardiology, 2006, Jan-17, Volume: 47, Issue:2 Topics: Coronary Disease; Coronary Vessels; Humans; Paclitaxel; Stents; Ultrasonography, Interventional	2006
Early outcome of treatment of ostial de novo left anterior descending coronary artery lesions with drug-eluting stents. The American journal of cardiology, 2006, Jan-15, Volume: 97, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Sirolimus; Stents	2006
Comparison of short- and mid-term outcomes between CYPHER and TAXUS stents in patients with complex lesions of the coronary arteries. Chinese medical journal, 2006, Jan-05, Volume: 119, Issue:1 Topics: Coronary Disease; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Stents	2006
Failure to retrieve undeployed paclitaxel-eluting coronary stents. The American journal of cardiology, 2006, Feb-15, Volume: 97, Issue:4 Topics: Aged; Coronary Disease; Device Removal; Equipment Design; Equipment Failure; Humans; Middle Aged; Paclitaxel; Retrospective Studies; Stents	2006
Comparison of ticlopidine vs. clopidogrel in addition to aspirin after paclitaxel-eluting stent implantation: insights from the TRUE (Taxusin Real-life Usage Evaluation) Study. International journal of cardiology, 2006, Apr-14, Volume: 108, Issue:3 Topics: Aspirin; Clopidogrel; Coronary Disease; Coronary Restenosis; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Paclitaxel; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Treatment Outcome	2006
[The effect of paclitaxel-eluting stents on restenosis]. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2006, Volume: 6, Issue:1 Topics: Animals; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Humans; Paclitaxel; Platelet Aggregation Inhibitors; Random Allocation; Secondary Prevention; Stents; Swine; Ticlopidine; Tunica Intima; Ultrasonography, Interventional	2006
Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention in the drug-eluting stent era: an integrated clinical and angiographic analysis based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Journal of the American College of Cardiology, 2006, Apr-18, Volume: 47, Issue:8 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Female; Humans; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Predictive Value of Tests; Sirolimus; Stents; Treatment Outcome	2006
Successful retrieval of dislodged paclitaxel-eluting stent with a nitinol loop snare: a case report. The Kaohsiung journal of medical sciences, 2005, Volume: 21, Issue:12 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Drug Delivery Systems; Humans; Male; Middle Aged; Paclitaxel; Stents	2005
Comparison between sirolimus- and Paclitaxel-eluting stents for the treatment of chronic total occlusions. The Journal of invasive cardiology, 2006, Volume: 18, Issue:5 Topics: Adult; Chronic Disease; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Heart Diseases; Humans; Inpatients; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Survival Analysis; Treatment Outcome	2006
Sirolimus or paclitaxel drug-eluting stents for treatment of chronic total occlusions of coronary arteries: much ado about very little. The Journal of invasive cardiology, 2006, Volume: 18, Issue:5 Topics: Chronic Disease; Coronary Disease; Humans; Paclitaxel; Sirolimus; Stents	2006
Drug eluting stents: data from a clinical registry. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2006, Volume: 16, Issue:5 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Female; Humans; Male; Middle Aged; Paclitaxel; Registries; Retrospective Studies; Sirolimus; Stents	2006
Sirolimus-eluting stents versus Paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus. The American journal of cardiology, 2006, Jul-15, Volume: 98, Issue:2 Topics: Aged; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Disease; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Prospective Studies; Sirolimus; Stents; Treatment Outcome	2006
Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease. Journal of the American College of Cardiology, 2006, Jul-18, Volume: 48, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Disease; Coronary Restenosis; Cost Savings; Costs and Cost Analysis; Diabetic Angiopathies; Female; Germany; Health Services; Hospital Costs; Hospitalization; Humans; Male; Middle Aged; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus	2006
Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial. Journal of the American College of Cardiology, 2006, Jul-18, Volume: 48, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Disease; Cost-Benefit Analysis; Double-Blind Method; Female; Health Care Costs; Health Services; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Retreatment; Stents; Treatment Outcome; United States	2006
Common sense, dollars and cents, and drug-eluting stents. Journal of the American College of Cardiology, 2006, Jul-18, Volume: 48, Issue:2 Topics: Angioplasty, Balloon, Coronary; Cardiovascular Agents; Coronary Disease; Cost Savings; Cost Sharing; Cost-Benefit Analysis; Economics, Hospital; Health Care Costs; Humans; Medicare; Paclitaxel; Stents; United States	2006
Impact of sirolimus-eluting and Paclitaxel-eluting stents on outcome in patients with diabetes mellitus and stenting in more than one coronary artery. The American journal of cardiology, 2006, Aug-01, Volume: 98, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Angiography; Coronary Disease; Diabetes Mellitus; Female; Follow-Up Studies; Hospital Mortality; Humans; Immunosuppressive Agents; Male; Middle Aged; Odds Ratio; Paclitaxel; Prospective Studies; Sirolimus; Stents; Treatment Outcome	2006
Failure to retrieve undeployed paclitaxel-eluting coronary stents. The American journal of cardiology, 2006, Aug-01, Volume: 98, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Disease; Device Removal; Humans; Paclitaxel; Prosthesis Failure; Reoperation; Retrospective Studies; Stents; Treatment Failure	2006
Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome study. Journal of the American College of Cardiology, 2006, Sep-19, Volume: 48, Issue:6 Topics: Aged; Chronic Disease; Coronary Disease; Coronary Stenosis; Diabetic Angiopathies; Drug Delivery Systems; Equipment Design; Female; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Male; Metals; Middle Aged; Multicenter Studies as Topic; Paclitaxel; Prolapse; Randomized Controlled Trials as Topic; Risk Assessment; Sirolimus; Stents; Treatment Outcome; Ultrasonography, Interventional	2006
[Economic impact of the taxus coronary stent: implications for the Spanish healthcare system]. Revista espanola de cardiologia, 2006, Volume: 59, Issue:9 Topics: Coronary Disease; Cost-Benefit Analysis; Drug Delivery Systems; Health Care Costs; Humans; Models, Economic; Paclitaxel; Spain; Stents	2006
Twelve-month outcomes with a paclitaxel-eluting stent transitioning from controlled trials to clinical practice (the WISDOM Registry). The American journal of cardiology, 2006, Oct-15, Volume: 98, Issue:8 Topics: Coronary Disease; Diabetes Complications; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Randomized Controlled Trials as Topic; Registries; Stents; Survival Rate; Treatment Outcome; Tubulin Modulators	2006
Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry. Circulation, 2006, Nov-14, Volume: 114, Issue:20 Topics: Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Coronary Disease; Drug Delivery Systems; Equipment Design; Humans; Incidence; Metals; Myocardial Infarction; Paclitaxel; Registries; Retreatment; Risk Assessment; Sirolimus; Stents; Thrombosis; Treatment Outcome	2006
Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention. The American journal of cardiology, 2006, Dec-15, Volume: 98, Issue:12 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Disease-Free Survival; Female; Humans; Male; Middle Aged; Paclitaxel; Sirolimus; Stents; Treatment Outcome	2006
Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death. The American journal of cardiology, 2007, Feb-01, Volume: 99, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Coronary Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Metals; Middle Aged; Myocardial Infarction; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Survival Rate; United States	2007
Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. The American journal of cardiology, 2007, Feb-01, Volume: 99, Issue:3 Topics: Aged; Angioplasty, Balloon, Coronary; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Metals; Middle Aged; Paclitaxel; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Treatment Outcome	2007
Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. International journal of cardiology, 2007, Dec-15, Volume: 123, Issue:1 Topics: Aged; Antineoplastic Agents, Phytogenic; Coated Materials, Biocompatible; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Time Factors; Treatment Outcome	2007
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. The New England journal of medicine, 2007, Mar-08, Volume: 356, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Prosthesis Design; Prosthesis Failure; Registries; Risk; Sirolimus; Stents; Sweden	2007
Unanswered questions--drug-eluting stents and the risk of late thrombosis. The New England journal of medicine, 2007, Mar-08, Volume: 356, Issue:10 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Thrombosis; Device Approval; Drug Delivery Systems; Humans; Myocardial Infarction; Paclitaxel; Prosthesis Design; Prosthesis Failure; Risk; Sirolimus; Stents; United States; United States Food and Drug Administration	2007
Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantation. Heart (British Cardiac Society), 2007, Volume: 93, Issue:9 Topics: Aged; Angioplasty, Balloon, Coronary; Biomarkers; C-Reactive Protein; Coronary Angiography; Coronary Disease; Coronary Restenosis; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Prognosis; Stents	2007
Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries. The American journal of cardiology, 2007, Mar-01, Volume: 99, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Cohort Studies; Coronary Disease; Equipment Design; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Survival Rate; Treatment Outcome; Tubulin Modulators	2007
Thrombosis: the last frontier of coronary stenting? Lancet (London, England), 2007, Feb-24, Volume: 369, Issue:9562 Topics: Antineoplastic Agents, Phytogenic; Coronary Disease; Coronary Thrombosis; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Stents	2007
Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. Journal of psychosomatic research, 2007, Volume: 62, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Coated Materials, Biocompatible; Coronary Disease; Depression; Fatigue; Female; Humans; Male; Middle Aged; Motivation; Myocardial Infarction; Paclitaxel; Prognosis; Proportional Hazards Models; Risk Factors; Stents; Survival Rate	2007
Late stent thrombosis: a not negligible issue after drug-eluting stent implantation. Chinese medical journal, 2007, Apr-05, Volume: 120, Issue:7 Topics: Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Thrombosis; Drug Delivery Systems; Humans; Paclitaxel; Sirolimus; Stents	2007
Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions. Chinese medical journal, 2007, Apr-05, Volume: 120, Issue:7 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Myocardial Revascularization; Paclitaxel; Sirolimus; Stents	2007
Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent. Chinese medical journal, 2007, Apr-05, Volume: 120, Issue:7 Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Drug Delivery Systems; Female; Humans; Male; Middle Aged; Paclitaxel; Retrospective Studies; Sirolimus; Stents	2007
Late thrombosis of a drug-eluting stent presenting in the perioperative period. Anesthesiology, 2007, Volume: 106, Issue:5 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Thrombosis; Drug Delivery Systems; Humans; Male; Paclitaxel; Postoperative Complications; Stents	2007
Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice. Journal of the American College of Cardiology, 2007, Jun-19, Volume: 49, Issue:24 Topics: Aged; Antineoplastic Agents, Phytogenic; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Sirolimus; Stents; Treatment Outcome	2007
Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. American heart journal, 2007, Volume: 154, Issue:4 Topics: Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Diabetic Angiopathies; Follow-Up Studies; Humans; Immunosuppressive Agents; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Risk Factors; Sirolimus; Stents; Survival Analysis; Treatment Outcome	2007
[Long-term clinical benefits of using active stents in diabetic patients: two year follow-up of a consecutive series of 122 patients]. Archives des maladies du coeur et des vaisseaux, 2007, Volume: 100, Issue:10 Topics: Aged; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Sirolimus; Survival Analysis; Treatment Outcome	2007
Short- and long-term effects of a novel paclitaxel coated stent in the porcine coronary model. Clinical research in cardiology : official journal of the German Cardiac Society, 2008, Volume: 97, Issue:2 Topics: Angioplasty, Balloon, Coronary; Animals; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Drug-Eluting Stents; Follow-Up Studies; Paclitaxel; Probability; Random Allocation; Risk Factors; Survival Rate; Swine; Swine, Miniature; Time Factors; Treatment Outcome	2008
Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: a prospective multicenter registry. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2008, Jan-01, Volume: 71, Issue:1 Topics: Aged; Coated Materials, Biocompatible; Comorbidity; Coronary Angiography; Coronary Disease; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Paclitaxel; Prospective Studies; Registries	2008
Sicilian DES Registry: prospective in-hospital and 9-month clinical and angiographic follow-up in selected high restenosis risk patients. Journal of cardiovascular medicine (Hagerstown, Md.), 2008, Volume: 9, Issue:2 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Coronary Restenosis; Diabetic Angiopathies; Drug-Eluting Stents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Registries; Sicily; Sirolimus	2008
Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation. American heart journal, 2008, Volume: 155, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Blood Vessel Prosthesis Implantation; China; Coated Materials, Biocompatible; Coronary Angiography; Coronary Disease; Coronary Restenosis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Male; Metals; Middle Aged; Myocardial Revascularization; Paclitaxel; Retrospective Studies; Sirolimus; Stents; Time Factors; Treatment Outcome; Ultrasonography, Interventional	2008
Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). Journal of the American College of Cardiology, 2008, Mar-11, Volume: 51, Issue:10 Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Coronary Thrombosis; Disease-Free Survival; Drug-Eluting Stents; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Paclitaxel; Proportional Hazards Models; Registries; Sirolimus; Stroke Volume	2008
Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients. American heart journal, 2008, Volume: 155, Issue:4 Topics: Aged; Coronary Disease; Coronary Restenosis; Coronary Thrombosis; Drug Administration Schedule; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Risk Factors; Statistics, Nonparametric	2008
Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus. The American journal of cardiology, 2008, May-01, Volume: 101, Issue:9 Topics: Blood Vessel Prosthesis Implantation; Chi-Square Distribution; Coronary Disease; Diabetes Mellitus; Drug-Eluting Stents; Female; Humans; Insulin; Logistic Models; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Registries; Retrospective Studies; Sirolimus; Treatment Outcome	2008
Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. Journal of the American College of Cardiology, 2000, Volume: 36, Issue:7 Topics: Angiogenesis Inhibitors; Animals; Coronary Disease; Drug Delivery Systems; Paclitaxel; Rabbits; Recurrence; Stents; Time Factors; Tunica Intima	2000
Paclitaxel-coated stent: is there a light at the end of the tunnel? Journal of the American College of Cardiology, 2001, Volume: 38, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Coronary Disease; Drug Delivery Systems; Female; Male; Models, Animal; Paclitaxel; Rabbits; Secondary Prevention; Sex Factors; Stents	2001
Late acute thrombosis after paclitaxel eluting stent implantation. Heart (British Cardiac Society), 2001, Volume: 86, Issue:3 Topics: Acute Disease; Angiogenesis Inhibitors; Aspirin; Coronary Disease; Coronary Thrombosis; Drug Implants; Humans; Male; Middle Aged; Myocardial Infarction; Paclitaxel; Platelet Aggregation Inhibitors; Recurrence; Risk Factors; Stents; Ticlopidine; Time Factors	2001
Highlights from the American Heart Association annual scientific sessions 2001: November 11 to 14, 2001. American heart journal, 2002, Volume: 143, Issue:2 Topics: American Heart Association; Antineoplastic Agents; Carotid Artery Diseases; Coronary Disease; Coronary Restenosis; Drug Delivery Systems; Humans; ortho-Aminobenzoates; Paclitaxel; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Stents	2002